Genomadix
ON - KanataDiagnostics
Focus: Genomadix is a newly founded (2024) diagnostics company specializing in portable PCR technology, positioned in the neurology space. The company is publicly listed but remains in early-stage deployment with minimal commercial traction.
Profile data last refreshed 7h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
2
Should You Work at Genomadix?
AI assessmentGenomadix is a high-risk, high-reward early-stage play suited only for risk-tolerant professionals seeking equity upside and technical autonomy; career progression and stability cannot be assured.
Why Work Here
- Ground-floor opportunity at a newly public diagnostics company with proprietary portable PCR platform technology
- Active hiring in Manufacturing (2 roles) and Commercial (1 role) suggests scaling phase and commercialization push
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Genomadix
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.